Here are updates on five orthopedic and spine device company stock reports and ratings.
1. Globus Medical — the company was upgraded to "Neutral" by Zacks, according to a Sleek Money report. Zacks has a $21.20 price objective o the stock. At the same time, Canaccord Genuity reiterated their "buy" rating for Globus Medical with a price target at $28, up from the previous $24 target.
2. Zimmer — Zacks reiterated its neutral rating for Zimmer last week, with a $115 price target on Zimmer stock.
3. NuVasive — Canaccord Genuity analysts reiterated a "buy" rating on NuVasive shares with a price objective of $49, which would suggest a potential upside of 17.93 percent, according to a Sleek Monkey report. Barclays reaffirmed an "equal weight" rating in a Friday report with a $44 price objective on NuVasive stock, up from the previous $42.
4. Baxano Surgical — Baxano Surgical experienced a significant drop in short interest for October, according to a Ticker Report. The company's short interest decreased 55.6 percent from the Sept. 30 total, with around 1.6 percent of the company's stock being short sold.
5. Smith & Nephew — Jeffries Group restated a "hold" rating for Smith & Nephew shares last week with a target price of $15.94. Credit Suisse reiterated a "neutral" rating for the company as well with a price target of $15.06 on the stock. Morgan Stanley reiterated an equal weight rating on Smith & Nephew shares and lowered their price target to $15.65.
More articles on orthopedic devices:
Zimmer Biomet names new leaders
Mazor Robotics, K2M, Wright Medical Group & more—17 key notes
10 key concepts from Smith & Nephew's financial report